Raymond James analyst Alexander Sklar lowered the firm’s price target on Weave (WEAV) to $15 from $17 and keeps a Strong Buy rating on the shares. Weave’s Q2 results featured a top and bottom line beat with progress against several of its growth initiatives, the analyst tells investors in a research note. Weave is one of the more likely candidates in its coverage to deliver top-line acceleration in a tough macro while also expanding margins, the firm says.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WEAV:
